News & Events

NOBLE gears up for capital markets in shipping with equity analyst hire

NEW YORK October 5, 2017 / TradeWinds

News

Boutique bank appoints veteran oil and energy specialist as its prepares for US roadshows

Noble Capital has taken its next step towards entering the US capital markets by hiring an equity analyst with extensive experience in the oil and energy sectors. Speaking to TradeWinds on the sidelines of this week’s Capital Link Maritime Forum in New York, Poe Fratt said Noble was gearing up to launch coverage within 2017.

Camillo Ricordi, M.D. new member NOBLE's Scientific Advisory Board (SAB)

Boca Raton, Florida, October 3, 2017

News

NOBLE Life Science Partners (NOBLE LSP), a division of Noble Capital Markets Inc. welcomes Camillo Ricordi, M.D. to its Scientific Advisory Board (SAB)

NOBLE Capital Markets follow-on offering co-manager Kratos Defense & Security Solutions, Inc. (USD 197,225,000)

San Diego, September 07, 2017 / Globe Newswire

News

Kratos Defense & Security Solutions, Inc. (“Kratos”) (Nasdaq:KTOS), announced today the pricing of an underwritten offering of 14,000,000 shares of its common stock at a public offering price of $12.25 per share.

ProMIS Neurosciences Completes Second Closing of Private Placement

TORONTO, ONTARIO, August 28, 2017

News

Noble Capital Markets, Inc., acting as the exclusive placement agent for subscribers residing in the United States,

Noble Capital Markets Initiates Research Coverage on Vectrus Inc. (VEC)

NEW YORK, August 17, 2017 /Marketwired

News

NOBLE Capital Markets, a leading small-cap focused investment firm, announces the initiation of research coverage of Vectrus Inc.

As big boys retreat from shipping, one bank goes fishing for minnows

NEW YORK August 9, 2017 / TradeWinds

News

With the traditional players exiting the sector or gravitating towards the mega-owners, Noble Capital has spotted a gap in the market

Noble Capital Markets Initiates Research Coverage on Marlin Gold Mining Ltd. (MLN.V / MLNGF)

NEW YORK, April 18, 2017 / PRNewswire

News

Noble Capital Markets announced today that it has initiated research coverage on Marlin Gold Ltd. (TSXV: MLN.V, OTCQX: MLNGF). The report was issued by Senior Research Analyst, Michael Heim, CFA.

Noble Capital Markets Initiates Research Coverage on AAR Corp. (AIR)

NEW YORK, April 3, 2017 /PRNewswire

News

Noble Capital Markets announced today that it has initiated research coverage on AAR Corp. (AIR). The report was issued by Research Analyst, Benjamin Klieve, CFA.

Noble Capital Markets Media Finance and Investor Program at NAB SHOW, Vegas -Hosts of Pawn Stars, Bar Rescue, Larry King and Facebook to Headline

LAS VEGAS, NV--(Marketwired - April 03, 2017)

Event

Noble Capital Markets (Noble) announced today that it will host its Fourth Annual Media, Finance and Investor Program produced in Partnership with the National Association of Broadcasters (NAB) to be held at the Las Vegas Convention Center (LVCC), April 24-25, 2017.

Noble Capital Markets Initiates Research Coverage on DLH Holdings Corp. (DLHC)

NEW YORK, Feb. 23, 2017 /PRNewswire

News

Noble Capital Markets announced today that it has initiated research coverage on DLH Holdings Corp. (DLHC). The report was issued by Senior Research Analyst, Mark Jordan, CFA.

Noble Capital Markets Initiates Research Coverage on ESSA Pharma Inc. (EPIX)

NEW YORK, Feb. 17, 2017 /PRNewswire

News

Noble Capital Markets announced today that it has initiated research coverage on ESSA Pharma Inc. (EPIX). The report was issued by Noble's Head of Biotechnology Research, Kumar Raja, PhD.

Noble Capital Markets Initiates Research Coverage on Endeavour Silver Corp. (EXK)

NEW YORK, Feb. 16, 2017 /PRNewswire

News

Noble Capital Markets announced today that it has initiated research coverage on Endeavour Silver Corp. (EXK). The report was issued by Senior Research Analyst, Michael Heim, CFA.

Noble Capital Markets Initiates Research Coverage on Anavex Life Sciences Corp. (AVXL)

NEW YORK, Feb. 7, 2017 /PRNewswire

News

Noble Capital Markets announced today that it has initiated research coverage on Anavex Life Sciences Corp. (AVXL) The report was issued by Noble's Head of Biotechnology Research, Kumar Raja, PhD.

Noble Financial Expands Its Life Sciences Investment Banking Division in Time for NobleCon13.

November 14, 2016 – Boca Raton, Florida

News

Noble Life Science Partners, a division of Noble Financial Capital Markets (Noble) announced today that Nathan Cali, formerly Noble’s specialty pharmaceuticals senior analyst, has moved to its investment banking department.

Company that attended Noble Financial’s NobleCon10, 11 & 12 – Cynapsus Therapeutics – acquired by Sunovion Pharmaceuticals

November 7, 2016 – Boca Raton, Florida

News

Noble Life Science Partners, a division of Noble Financial Capital Markets (Noble) announced today that Cynapsus Therapeutics, Inc. (Cynapsus – NASADQ;CYNA) will no longer attend its fourth consecutive Noble Investor Conference - NobleCon13 to be held at the Boca Raton Resort & Club, January 30-31, 2017 – as it has been acquired by Sunovion Pharmaceuticals, at a purchase price of $624 million USD ($820 million CND). Noble was the first to initiate equity research coverage on Cynapsus and has supported the company’s growth through three rounds of financing totaling in excess of $100 million USD.

A move to our home base. An elegant departure from the ordinary.

June 1, 2016 – Boca Raton, Florida

event

NOBLE FINANCIAL capital markets will be holding their thirteenth annual conference in their hometown of Boca Raton, Florida.

Noble Financial expanding its media-sector team, following successful Media Finance and Investor Conference held in partnership with NAB

May 23, 2016 – Boca Raton, Florida

News

Noble Financial Capital Markets (Noble) announced today that it plans to expand its media sector team of analysts and investment bankers following the success of the Media Finance & Investor Conference (MFIC) held in Las Vegas last month. The Conference is produced in partnership with the National Association of Broadcasters (NAB) and was the partnership’s third annual event.

Pelican Therapeutics awarded $15.2 million to develop novel immune therapy for multiple cancers

PR Newswire, May 19, 2016

News

Pelican Therapeutics announced today that it won a $15,245,222 million New Company Product Development Award from the Cancer Prevention and Research Institute of Texas (CPRIT).

Triangle biotech companies seek cash in down market

The News Observer, March 26, 2016

News

When an unprecedented five Triangle-based biotechnology companies went public in 2013 and 2014, the mood on Wall Street was ebullient.

Noble LSP joins a panel at the Moffitt Cancer Center, “Immuno-Oncology: An Expanding Frontier”

Business of Biotech – March 18, 2016

News

Rahul Jasuja, PhD Managing Director, Biotechnology Research NOBLE Life Science Partners will be a panelist at the “Immuno-Oncology: An Expanding Frontier” discussion at the Business of Biotech Conference hosted by the Moffitt Cancer Center – March 18, 2016

1234